Clinical Trial Update: A Comparison of SLx-4090 in Combination With Metformin Versus Metformin Therapy Alone in Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial comparing SLx-4090 plus metformin vs metformin alone in type 2 diabetes completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SLx-4090 (SLx-4090)
• metformin (metformin)

Snippet

Sponsor: Response Pharmaceuticals | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED